HI SCR172 | 2018 | Regular Session

Note: Carry Over of previous SCR172

Status

Spectrum: Partisan Bill (Democrat 9-0)
Status: Introduced on March 9 2018 - 25% progression, died in committee
Action: 2018-03-16 - Referred to PSM, CPH.
Pending: Senate Public Safety, Intergovernmental and Military Affairs Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Urging The United States Food And Drug Administration, The United States Surgeon General, And Hawaii's Congressional Delegation To Consider Whether Products Containing Oxybenzone Should Include A Warning Label That Addresses Human Health Risks.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Urging The United States Food And Drug Administration, The United States Surgeon General, And Hawaii's Congressional Delegation To Consider Whether Products Containing Oxybenzone Should Include A Warning Label That Addresses Human Health Risks.

Sponsors


History

DateChamberAction
2018-03-16SenateReferred to PSM, CPH.
2018-03-09SenateOffered.

Same As/Similar To

SCR172 (Carry Over) 2017-03-29 - Report adopted, referred to CPH.

Subjects


Hawaii State Sources


Bill Comments

feedback